Bupropion Hydrochloride (xl) Tablet, Extended Release
Product Images NDC 69680-157

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (xl) (NDC 69680-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg1000s (150mg1000s)

150mg1000s (150mg1000s)
Packaging label for Bupropion hydrochloride Extended-Release Tablets, USP (XL) 150 mg, oral extended release tablets supplied in a 1000 tablet count. The label includes barcodes, storage instructions, dispensing warnings, and manufacturer details. The labeler is Vitruvias Therapeutics, and the product is manufactured in China.*
FDA Label Image

150mg30s (150mg30s)

150mg30s (150mg30s)
Label for Bupropion hydrochloride Extended-Release Tablets, USP (XL) 150 mg, once-daily oral tablets. The carton contains 30 tablets and is labeled for prescription use only. Distributed by Vitruvias Therapeutics, manufactured by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., China. Includes dosing and storage information.*
FDA Label Image

150mg500s (150mg500s)

150mg500s (150mg500s)
Label for Bupropion hydrochloride Extended-Release Tablets USP (XL) 150 mg by Vitruvias Therapeutics. The label indicates a once-daily oral tablet with a package containing 500 tablets. It includes storage instructions and manufacturer details, noting production in China by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.*
FDA Label Image

150mg90s (150mg90s)

150mg90s (150mg90s)
Label for Bupropion hydrochloride Extended-Release Tablets USP (XL) 150 mg, oral tablets supplied by Vitruvias Therapeutics. The label indicates a 90 tablet count and includes storage instructions, manufacturer information (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., China), and a warning about drug interactions with Zyban. The label also includes dosing guidance to take one tablet daily or as directed.*
FDA Label Image

300mg1000s (300mg1000s)

300mg1000s (300mg1000s)
Label for Bupropion hydrochloride Extended-Release Tablets, USP (XL) 300 mg by Vitruvias Therapeutics. The label includes dosage form as extended-release tablets, container size of 1000 tablets, and manufacturer information indicating production by Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. in China. It has warnings and pharmacy dispensing instructions.*
FDA Label Image

300mg30s (300mg30s)

300mg30s (300mg30s)
Label for Bupropion hydrochloride Extended-Release Tablets USP (XL), 300 mg strength. The label states it is for once-daily oral use and comes as a package of 30 tablets. Labeler is Vitruvias Therapeutics. The label includes storage instructions and a warning not to use with Zyban or medicines containing bupropion HCl. Distributed by Vitruvias Therapeutics, manufactured in China.*
FDA Label Image

300mg500s (300mg500s)

300mg500s (300mg500s)
Label for buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg by Vitruvias Therapeutics. The oral extended-release tablet container holds 500 tablets. The label includes dosage and storage information, manufacturer details (Hangzhou Minsheng Binjiang Pharmaceutical), and warnings about drug interactions.*
FDA Label Image

300mg90s (300mg90s)

300mg90s (300mg90s)
Drug facts panel for Bupropion hydrochloride Extended-Release Tablets, USP (XL) 300 mg. The label details dosage, storage instructions, manufacturer information (Hangzhou Minsheng Binjiang Pharmaceutical Co., China), distributor (Vitruvias Therapeutics), warning against use with ZYBAN and related medicines, and prescription-only status. It includes a barcode and package quantity of 90 tablets.*
FDA Label Image

Formula (Image)

Formula (Image)
Chemical structure of bupropion hydrochloride showing its molecular arrangement including a chlorophenyl group, a ketone functional group, and a tertiary butyl group with a hydrochloride salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.